Depression affects up to 20% of adults and 25% of teens in the U.S. and is among the leading causes of disability around the world. Psychotherapy and psychiatric medication remain the first-line treatment, yet it's estimated that 30% of people do not experience relief from these interventions. Emerging research is identifying "inflammatory depression" as a distinct subtype that tends towards treatment resistance. This engaging presentation covers the foundations of addressing neuroinflammation in your patients with depression, including the most current research on root causes, assessment, as well as natural and integrative treatment options.
Learning objectives:
Additional Instructors: